Zolinza 100 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FJF76
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,185
Award facts
- Contract value 100% obligated
- $10,184.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zolinza 100 mg capsules (120 count) with a ceiling value of $10,184.69. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence through its extensive portfolio with the Defense Logistics Agency and its Medical Supply Chain. The company's federal procurement activities demonstrate consistent capability to fulfill diverse medical supply needs across multiple therapeutic domains, serving defense healthcare stakeholders including the Defense Health Agency and U.S. Coast Guard. Zolinza (vorinostat) is a prescription medication used in treating certain types of cancer, reflecting the pharmaceutical distributor's critical role in supplying specialized oncology treatments to federal medical systems.
Quick answers
Who was awarded contract SPE2DB25FJF76?
SPE2DB25FJF76 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FJF76 worth?
The government has obligated $10,185 on SPE2DB25FJF76.
Is contract SPE2DB25FJF76 an order under another contract?
Yes. SPE2DB25FJF76 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJF76 competed?
The extent of competition for SPE2DB25FJF76 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award